Acta Scientific Pharmaceutical Sciences (ASPS)(ISSN: 2581-5423)

Review Article Volume 5 Issue 11

Synthetic Approaches and Biological Activities of Heterocyclic Pyrazoline

Amana Parveen, Shashi Kiran Misra, Anupriya Kapoor, Yuthika Narayan, Shivam Kumar Verma, Pramod Chauhan and Ajay Kumar*

School of Pharmaceutical Sciences, CSJM University, Kanpur, India

*Corresponding Author: Ajay Kumar, School of Pharmaceutical Sciences, CSJM University, Kanpur, India.

Received: October 05, 2021; Published: October 25, 2021



Nitrogen-containing heterocyclic combinations are widely explored in the synthesis and development of a variety of chemicals in therapeutic sciences. Pyrazolines are one of the major heterocyclic molecules that take a crucial part by the virtue of their pharmacological properties, pyrazolines are remarkable and enormousnitrogen-containing 5-membered heterocyclic combinations and various methods for their mixing have been shown. Several subordinates of pyrazoline were found to have significant normal activities, which revived the development of assessment in this area. They have a couple of prominent effects, similar to antimicrobial, antimycobacterial, antifungal, antiamoebic, alleviating, torment easing, upper and anticancer activities. 2-pyrazolines give off an impression of being the regularly pondered pyrazoline-type compounds. These combinations are by and large prepared from the cyclization of chalcones with hydrazine and its auxiliaries under alcoholic conditions. Pyrazolines are the diminished types of pyrazoles Subsequently, a tremendous number of such pyrazolines using particularly designed methods for their arranging have been portrayed in this article. The current study gives an understanding viewpoint to pyrazolines synthesis and its biological activities.

Keywords: Pyrazole; Pyrazoline; Synthesis; Biological Activities; Pharmacological Properties; Chalcone



  1. Shajidul K., et al. “Pyrazoline Heterocyclic: A Review”. International Journal of Pharmaceutical Science and Research 5 (2021): 2570-2588.
  2. Donald JA., et al. “Burger’s Medicinal Chemistry and Drug Discovery”. 6th edition, John Wiley and Sons, New Jersey (2007): 539-543.
  3. Olczak‐Kowalczyk D., et al. “Bacteria and Candida yeasts in inflammations of the oral mucosa in children with secondary immunodeficiency”. Journal of Oral Pathology and Medicine7 (2012): 568-576.
  4. Ahasan NB., et al. “Cytotoxicity study of pyrazole derivatives”. Bangladesh Journal of Pharmacology 2 (2007): 81-87.
  5. Abunada NM., et al. “Synthesis and biological activity of some new pyrazoline and pyrrolo [3, 4-c] pyrazole-4, 6-dione derivatives: reaction of nitrilimines with some dipolarophiles”. Molecules4 (2008): 1011-1024.
  6. Ziani N., et al. “Synthesis of pyrazoline derivatives from the 1, 3-dipolar cycloadditions using α, β-unsaturated cyclohexanone derivatives”. European Journal of Chemistry2 (2013): 176-179.
  7. Mahdi MF., et al. “Synthesis, characterization and preliminary pharmacological evaluation of new non-steroidal anti-inflammatory pyrazoline derivatives”. European Journal of Chemistry4 (2015): 461-467.
  8. Sharma TC., et al. “Synthesis of some isomeric pyrazoles”. Chemischer Informations Dienst36 (1983).
  9. Varghese B., et al. “Unveiling a versatile heterocycle: pyrazoline–a review”. RSC Advances74 (2017): 46999-47016.
  10. 10.   Ju Y., et al. “Aqueous N-heterocyclization of primary amines and hydrazines with dihalides: microwave-assisted syntheses of N-azacycloalkanes, isoindole, pyrazole, pyrazolidine, and phthalazine derivatives”. The Journal of organic chemistry 71.1 (2006): 135-141.
  11. Lellek V., et al. “An Efficient Synthesis of Substituted Pyrazoles from One-Pot Reaction of Ketones, Aldehydes, and Hydrazine Monohydrochloride”. Synlett8 (2018): 1071-1075.
  12. 12.   Alex K., et al. “Zinc-catalyzed synthesis of pyrazolines and pyrazoles via hydrohydrazination”. Organic Letters 10.12 (2008): 2377-2379.
  13. Yang MN., et al. “Synthesis of dihydropyrazoles via ligand-free Pd-catalyzed alkene aminoarylation of unsaturated hydrazones with diaryliodonium salts”. Organic Letters19 (2017): 5208-5211.
  14. 14.   Cho CH., et al. “Solution-phase parallel synthesis of a multi-substituted benzo [b] thiophene library”. Journal of Combinatorial Chemistry 11.5 (2009): 900-906.
  15. Wang Z., et al. “Synthesis of 5- (trifluoromethyl) pyrazolines by formal [4+ 1]-annulation of fluorinated sulfur ylides and azoalkenes”. Organic letters4 (2018): 934-937.
  16. Cui SL., et al. “Facile access to pyrazolines via domino reaction of the Huisgen zwitterions with aziridines”. Organic Letters1 (2008): 13-16.
  17. Chen M., et al. “Copper-catalyzed diamination of alkenes of unsaturated ketohydrazones with amines”. Organic Letters3 (2018): 510-513.
  18. Sharifzadeh B., et al. “Facile regioselective synthesis of novel bioactive thiazolyl-pyrazoline derivatives via a three-component reaction and their antimicrobial activity”. Bioorganic and Medicinal Chemistry Letters2 (2013): 548-551.
  19. Patel PI., et al. “Design, synthesis and pharmacological evaluation of new series of pyrazolines based thiazolidin-4-one derivatives”. Chemical Science Transactions 4 (2013): 1089-93.
  20. Shah SH., et al. “Synthesis and Bio-Evaluation of Some New Phenyl Pyrazoline Derivatives from Pera-ChloroBenzaldehyde Moiety”. Journal of Chemistry and Chemical Sciences 1 (2014): 1-7.
  21. Misra SK., et al. “Passage delaying microbeads for controlled delivery of loratadine”. PDA Journal of Pharmaceutical Science and Technology 6 (2008): 421-428.
  22. Kapoor A., et al. “Acitretin loaded nanocarrier gel: formulation and exploration of in – vitro release kinetics”. Current Nanomedicine 11 (2021): 1-10. 
  23. Gonjare NS., et al. “Synthesis and anti-inflammatory activity of some novel 1, 2-pyrazoline derivatives”. Der Pharma Chemica3 (2013): 86-91.
  24. Neethu NJ., et al. “Synthesis, Biological evaluation and Evaluation of Pyrazoline Analogues of Vanillin”. International Journal of Pharmaceutical Sciences and Drug Research 2 (2014): 128-131.
  25. Sridhar S., et al. “Synthesis and analgesic studies of some new 2-pyrazolines”. E-Journal of Chemistry4 (2012): 1810-1815.
  26. Mathew B., et al. “Synthesis, preclinical evaluation and antidepressant activity of 5-substituted phenyl-3- (thiophen-2-yl)-4, 5-dihydro-1H-pyrazole-1-carbothioamides”. EXCLI Journal 13 (2014): 437.
  27. Kaymakcioglu BK., et al. “Antidepressant-like activity of 2-pyrazoline derivatives”. Clinical and Experimental Health Sciences3 (2013): 154.
  28. Rao AS., et al. “Anticonvulsant and Antidepressant Activity Studies of Synthesized Some New 1, 3, 5-trisubstituted-2-pyrazolines”. International Journal of PharmTech Research 3 (2014): 1113-1123.
  29. Hayat F., et al. “Synthesis, characterization, antiamoebic activity and cytotoxicity of novel series of pyrazoline derivatives bearing quinoline tail”. European Journal of Medicinal Chemistry10 (2010): 4669-4675.
  30. Abid M., et al. "Synthesis and antiamoebic activities of 1-N-substituted cyclisedpyrazoline analogues of thiosemicarbazones”. Bioorganic and Medicinal Chemistry6 (2005): 2213-2220.
  31. Wani MY., et al. "Synthesis and in vitro evaluation of novel tetrazole embedded 1, 3, 5-trisubstituted pyrazoline derivatives as Entamoebahistolytica growth inhibitors”. European Journal of Medicinal Chemistry 54 (2012): 845-854.
  32. Misra SK., et al. “Anticancer potential of indole derivatives: an update”. Physical Sciences Review (2021).
  33. Kapoor A. “Biologics in the management of psoriasis”. Acta Scientific Pharmaceutical Science10 (2021): 77-83.
  34. Zhu SL., et al. "Design and stereoselective synthesis of novel isosteviol-fused pyrazolines and pyrazoles as potential anticancer agents”. European Journal of Medicinal Chemistry 65 (2013): 70-82.
  35. Raghav N., et al. "SAR studies of differently functionalized chalcones based hydrazones and their cyclized derivatives as inhibitors of mammalian cathepsin B and cathepsin H”. Bioorganic and Medicinal Chemistry15 (2014): 4233-4245.
  36. Lee M., et al. "A novel class of trans-methylpyrazoline analogs of combretastatins: synthesis and in-vitro biological testing”. European Journal of Medicinal Chemistry7 (2011): 3099-3104.
  37. Ramajayam R., et al. "Synthesis and evaluation of pyrazolone compounds as SARS-coronavirus 3C-like protease inhibitors”. Bioorganic and Medicinal Chemistry22 (2010): 7849-7854.
  38. Havrylyuk D., et al. "Synthesis and biological activity evaluation of 5-pyrazoline substituted 4-thiazolidinones”. European Journal of Medicinal Chemistry 66 (2013): 228-237.
  39. Shaharyar M., et al. "Synthesis and evaluation of in vitro antiviral activity of novel phenoxy acetic acid derivatives”. Journal of Enzyme Inhibition and Medicinal Chemistry3 (2009): 876-882.
  40. Hipparagi SM., et al. "Synthesis and evaluation of anti-tubercular activity of some novel 2-pyrazoline derivatives”. Journal of the Scientific Society2 (2013): 80.
  41. Hariraj N., et al. "Synthesis of certain pyrazoline-5-one derivatives of 6-bromo coumarins and evaluation of their biological activities”. Pharmacie Globale12 (2012): 1.
  42. Taj T., et al. "One-pot synthesis of pyrazolinederivatisedcarbazoles as antitubercular, anticancer agents, their DNA cleavage and antioxidant activities”. European Journal of Medicinal Chemistry9 (2011): 4366-4373.
  43. Kumar A., et al. "Synthesis and biological evaluation of new 4-bromo-3, 5-diaryl-1-phenyl-2-pyrazoline derivatives as antioxidant and anti-inflammatory agents”. International Journal of Research and Development in Pharmacy and Life Sciences2 (2013): 349-354.
  44. Venkatesh P., et al. “Synthesis of Coumarin fused Pyrazoline-5-one derivatives and Screening for their antimicrobial and antioxidant activite”. Journal of Pharmacy Research5 (2012): 2875-7.
  45. Kumar A., et al. "Synthesis and evaluation of antioxidant activity of novel 3, 5-disubstituted-2-pyrazolines”. Bulletin of Faculty of Pharmacy, Cairo University2 (2013): 167-173.
  46. Siddiqui AA., et al. "Synthesis and anticonvulsant activity of some substituted 3, 5-diphenyl-2-pyrazoline-1-carboxamide derivatives”. Chemical Science Journal, CSJ-8 (2010).
  47. Beyhan N., et al. "Synthesis and anticonvulsant activity of some 2-pyrazolines derived from chalcones”. Arabian Journal of Chemistry10 (2017): S2073-S2081.
  48. Rao B., et al. "Synthesis, characterization and evaluation of anti-epileptic activity of four new 2-pyrazoline derivatives compounds”. Scholars Journal of Applied Medical Sciences 1 (2013): 20-27.
  49. Ovais S., et al. "Synthesis and biological evaluation of some new pyrazoline substituted benzenesulfonylurea/thiourea derivatives as anti-hyperglycaemic agents and aldose reductase inhibitors”. European Journal of Medicinal Chemistry80 (2014): 209-217.
  50. Emayavaramban, M., et al. "Synthesis, Characterization and Anti-diabetic activity of 1, 3, 5-triaryl-2-pyrazolines in acetic acid solution under Ultrasound Irradiation”. International Letters of Chemistry, Physics and Astronomy9 (2013): 172-185.


Citation: Ajay Kumar., et al. “Synthetic Approaches and Biological Activities of Heterocyclic Pyrazoline". Acta Scientific Pharmaceutical Sciences 5.11 (2020): 59-69.


Acceptance rate32%
Acceptance to publication20-30 days
Impact Factor1.020

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is December 15, 2021.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US